STOCK TITAN

[Form 4] UiPath, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/21/2025, the officer sold 10,000 Class A shares at a price of $15.68 per share under a Rule 10b5-1 pre-arranged trading plan.

Following this sale, the officer beneficially owns 192,776 shares, held directly. This disclosure was filed on Form 4 and reflects a routine, planned transaction by a company officer.

UiPath (PATH) ha comunicato un'operazione interna da parte del suo Chief Accounting Officer. Il 21/10/2025, l'ufficiale ha venduto 10.000 azioni Class A al prezzo di $15,68 per azione, nell'ambito di un piano di trading pre-accordato secondo la Rule 10b5-1.

A seguito di questa vendita, l'ufficiale detiene beneficiariamente 192.776 azioni, detenute direttamente. Questa comunicazione è stata presentata sul Modulo 4 e riflette una transazione di routine pianificata da un dirigente dell'azienda.

UiPath (PATH) informó una operación interna por parte de su Director de Contabilidad. El 21/10/2025, el funcionario vendió 10.000 acciones de Clase A a un precio de $15.68 por acción bajo un plan de negociación preacordado conforme a la Regla 10b5-1.

Tras esta venta, el funcionario posee beneficiosamente 192.776 acciones, en forma directa. Esta divulgación fue presentada en el Formulario 4 y refleja una operación rutinaria y planificada por un funcionario de la empresa.

UiPath (PATH)는 최고재무책임자의 내부자 거래를 보고했습니다. 2025년 10월 21일에 그 임원이 Class A 주식 10,000주를 주당 $15.68에 매도했으며, 이는 Rule 10b5-1의 사전에 정해진 거래 계획에 따른 것입니다.

이번 매도 이후 임원은 직접 보유하는 192,776주의 지배적으로 소유합니다. 이 공시는 Form 4에 제출되었으며 회사 임원의 일상적이고 계획된 거래를 반영합니다.

UiPath (PATH) a communiqué une opération interne par son Chief Accounting Officer. Le 21/10/2025, l'officier a vendu 10 000 actions de classe A au prix de $15,68 par action dans le cadre d'un plan de trading préétabli conformément à la Rule 10b5-1.

Suite à cette vente, l'officier détient bénéficiairement 192 776 actions, détenues directement. Cette divulgation a été déposée sur le Formulaire 4 et reflète une transaction routinière et planifiée par un dirigeant de l'entreprise.

UiPath (PATH) meldete eine Insider-Transaktion durch seinen Chief Accounting Officer. Am 2025-10-21 hat der Beauftragte 10.000 Class-A-Aktien zu einem Preis von $15,68 pro Aktie im Rahmen eines vorab vereinbarten Handelsplans nach der Rule 10b5-1 verkauft.

Nach diesem Verkauf besitzt der Beauftragte wirtschaftlich 192.776 Aktien, die er direkt hält. Diese Offenlegung wurde im Formblatt 4 eingereicht und spiegelt eine routinemäßige, geplante Transaktion eines Unternehmensbeauftragten wider.

UiPath (PATH) أبلغت عن صفقة داخلية من قِبل رئيس المحاسبة. في 21/10/2025 قام المسؤول ببيع 10,000 سهم من فئة A بسعر $15.68 للسهم وفقاً لخطة تداول مُسبقة الترتيب وفقاً لـ Rule 10b5-1.

عقب هذا البيع، يمتلك المسؤول بصفة مستفيدة 192,776 سهماً بشكل مباشر. تم تقديم هذا الكشف على النموذج 4 ويعكس تعاملًا روتينيًا ومخططًا له من قبل مسؤول في الشركة.

UiPath (PATH) 报告了其首席会计官的内部人交易。于2025/10/21,该官员以每股$15.68的价格在Rule 10b5-1的预先安排交易计划下卖出10,000股A类股票。

此次出售后,该官员直接持有192,776股,受益所有权。该披露已在表格4上提交,反映了公司高管的常规、计划内交易。

Positive
  • None.
Negative
  • None.

UiPath (PATH) ha comunicato un'operazione interna da parte del suo Chief Accounting Officer. Il 21/10/2025, l'ufficiale ha venduto 10.000 azioni Class A al prezzo di $15,68 per azione, nell'ambito di un piano di trading pre-accordato secondo la Rule 10b5-1.

A seguito di questa vendita, l'ufficiale detiene beneficiariamente 192.776 azioni, detenute direttamente. Questa comunicazione è stata presentata sul Modulo 4 e riflette una transazione di routine pianificata da un dirigente dell'azienda.

UiPath (PATH) informó una operación interna por parte de su Director de Contabilidad. El 21/10/2025, el funcionario vendió 10.000 acciones de Clase A a un precio de $15.68 por acción bajo un plan de negociación preacordado conforme a la Regla 10b5-1.

Tras esta venta, el funcionario posee beneficiosamente 192.776 acciones, en forma directa. Esta divulgación fue presentada en el Formulario 4 y refleja una operación rutinaria y planificada por un funcionario de la empresa.

UiPath (PATH)는 최고재무책임자의 내부자 거래를 보고했습니다. 2025년 10월 21일에 그 임원이 Class A 주식 10,000주를 주당 $15.68에 매도했으며, 이는 Rule 10b5-1의 사전에 정해진 거래 계획에 따른 것입니다.

이번 매도 이후 임원은 직접 보유하는 192,776주의 지배적으로 소유합니다. 이 공시는 Form 4에 제출되었으며 회사 임원의 일상적이고 계획된 거래를 반영합니다.

UiPath (PATH) a communiqué une opération interne par son Chief Accounting Officer. Le 21/10/2025, l'officier a vendu 10 000 actions de classe A au prix de $15,68 par action dans le cadre d'un plan de trading préétabli conformément à la Rule 10b5-1.

Suite à cette vente, l'officier détient bénéficiairement 192 776 actions, détenues directement. Cette divulgation a été déposée sur le Formulaire 4 et reflète une transaction routinière et planifiée par un dirigeant de l'entreprise.

UiPath (PATH) meldete eine Insider-Transaktion durch seinen Chief Accounting Officer. Am 2025-10-21 hat der Beauftragte 10.000 Class-A-Aktien zu einem Preis von $15,68 pro Aktie im Rahmen eines vorab vereinbarten Handelsplans nach der Rule 10b5-1 verkauft.

Nach diesem Verkauf besitzt der Beauftragte wirtschaftlich 192.776 Aktien, die er direkt hält. Diese Offenlegung wurde im Formblatt 4 eingereicht und spiegelt eine routinemäßige, geplante Transaktion eines Unternehmensbeauftragten wider.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ramani Hitesh

(Last) (First) (Middle)
C/O UIPATH, INC., ONE VANDERBILT AVENUE
60TH FLOOR

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/21/2025 S 10,000(1) D $15.68 192,776 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
Remarks:
/s/ Brad Brubaker, Attorney-in-Fact 10/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UiPath (PATH) report?

The Chief Accounting Officer sold 10,000 Class A shares at $15.68 on 10/21/2025.

Was the UiPath (PATH) trade under a 10b5-1 plan?

Yes. The sale was executed under a Rule 10b5-1 qualified selling plan.

How many UiPath (PATH) shares does the officer now hold?

After the sale, the officer beneficially owns 192,776 shares, held directly.

What is the officer’s role at UiPath (PATH)?

The reporting person is an Officer, serving as Chief Accounting Officer.

What form reports this UiPath (PATH) transaction?

It is disclosed on Form 4, which reports insider trades.

What type of security was sold by UiPath’s officer?

The transaction involved Class A Common Stock of UiPath.
Uipath Inc

NYSE:PATH

PATH Rankings

PATH Latest News

PATH Latest SEC Filings

PATH Stock Data

8.46B
409.46M
9.44%
82.2%
10.47%
Software - Infrastructure
Services-prepackaged Software
Link
United States
NEW YORK